Table 1.
Demographic and clinical characteristics of the patients with cancer.
| Variables | All patients (N = 134) | Male (N = 82) | Female (N = 52) |
|---|---|---|---|
| Age, years | 58.4 ± 8.7 | 58.3 ± 8.3 | 58.6 ± 9.3 |
| BMI, kg/m 2 | 23.2 ± 3.0 | 22.9 ± 2.9 | 23.7 ± 3.1 |
| Tumor location, n (%) | |||
| Up 1/3 | 49 (36.57) | 32 (39.02) | 17 (32.69) |
| Middle 1/3 | 24 (17.91) | 11 (13.41) | 13 (25.00) |
| Low 1/3 | 61 (45.52) | 39 (47.56) | 22 (42.31) |
| Tumor size (cm) | 5.3 ± 3.1 | 5.2 ± 2.9 | 5.3 ± 2.8 |
| pTNM stage, n (%) | |||
| II | 36 (26.87) | 26 (31.71) | 10 (19.23) |
| III | 98 (73.13) | 56 (68.29) | 42 (80.77) |
| Handgrip strength (Kg) | 29.9 ± 8.0 | 33.9 ± 7.1 | 23.7 ± 4.7 |
| Albumin (g/L) | 42.4 ± 3.8 | 41.9 ± 3.8 | 43.5 ± 3.5 |
| Prealbumin (mg/L) | 213.8 ± 23.4 | 210.8 ± 26.3 | 214.1 ± 29.6 |
| Total protein (g/L) | 69.7 ± 17.1 | 68.9 ± 18.0 | 70.2 ± 19.4 |
| SMA (cm 2 ) | 123.2 ± 23.5 | 129.5 ± 20.7 | 113.2 ± 24.2 |
| SMI (cm 2 /m 2 ) | 43.1 ± 7.5 | 44.2 ± 6.5 | 41.4 ± 8.7 |
| Neutrophil counts, 10 9 /L | 3.5 ± 1.5 | 3.6 ± 1.5 | 3.2 ± 1.4 |
| Platelet counts, 10 9 /L | 196.9 ± 68.7 | 197.5 ± 66.9 | 195.9 ± 72.0 |
| Lymphocyte counts, 10 9 /L | 2.9 ± 1.1 | 2.6 ± 1.0 | 2.8 ± 1.3 |
| SII | 312.6 ± 253.4 | 330.6 ± 258.5 | 284.3 ± 244.9 |
| PNI | 55.8 ± 6.8 | 55.0 ± 6.7 | 57.0 ± 6.8 |
| Sarcopenia, n (%) | |||
| Yes | 31 (23.13) | 21 (25.61) | 10 (19.23) |
| No | 103 (76.87) | 61 (74.39) | 42 (80.77) |
BMI, body mass index; HGS, handgrip strength; SMA, skeletal muscle mass; SMI, skeletal muscle index; SII, systemic inflammatory immunity index; PNI, prognostic nutritional index. Values are presented as mean (SD) unless otherwise noted.